Literature DB >> 23525201

Knockdown of autophagy-related gene BECLIN1 promotes cell growth and inhibits apoptosis in the A549 human lung cancer cell line.

Wenyu Wang1, Hongkun Fan, Yun Zhou, Ping Duan, Guoqiang Zhao, Gang Wu.   

Abstract

The expression of BECLIN1 is significantly reduced in non‑small cell lung cancer (NSCLC) compared with non‑cancerous tissue. However, the role of BECLIN1 in lung cancer is unclear. Using the RNA interference (RNAi) technique the present study investigated the effect of the knockdown of BECLIN1 on the cell growth and proliferation of the A549 human lung cancer cell line. The target site for the RNAi technique was designed and the lentivirus vector for the small interfering (si)RNA expression was constructed according to the encoding sequence of the mRNA for BECLIN1. The A549 cells were transfected with the siRNA virus against BECLIN1. BECLIN1 expression was detected by reverse transcription (RT)‑PCR and western blot analysis. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method was applied to detect cell growth. Flow cytometry was used to determine cell apoptosis. The activity of caspase‑3 and caspase‑9 was also detected in the A549 cells with BECLIN1 knockdown. The results showed that siRNA virus transfection significantly decreased the mRNA and protein expression of BECLIN1 in the transfected A549 cells. The knockdown of BECLIN1 promoted cell growth and decreased apoptosis. Caspase‑3 and ‑9 activity in the A549 cells with BECLIN1 knockdown was significantly reduced. In conclusion, the siRNA expression vector effectively inhibited the expression of BECLIN1 in the A549 human lung cancer cell line and promote the growth and proliferation of the A549 cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23525201     DOI: 10.3892/mmr.2013.1379

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  15 in total

1.  Alisertib induces G2/M arrest, apoptosis, and autophagy via PI3K/Akt/mTOR- and p38 MAPK-mediated pathways in human glioblastoma cells.

Authors:  Zheng Liu; Feng Wang; Zhi-Wei Zhou; He-Chun Xia; Xin-Yu Wang; Yin-Xue Yang; Zhi-Xu He; Tao Sun; Shu-Feng Zhou
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

2.  AKT/mTOR and c-Jun N-terminal kinase signaling pathways are required for chrysotile asbestos-induced autophagy.

Authors:  Ziying Lin; Tie Liu; David W Kamp; Yahong Wang; Huijuan He; Xu Zhou; Donghong Li; Lawei Yang; Bin Zhao; Gang Liu
Journal:  Free Radic Biol Med       Date:  2014-04-13       Impact factor: 7.376

3.  Effect of beclin 1 expression on the biological behavior and chemotherapy sensitivity of cervical cancer cells.

Authors:  Yongxin Zhang; Shuang Lin; Yue Zhang; Suwen Chang
Journal:  Oncol Lett       Date:  2016-05-06       Impact factor: 2.967

4.  The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.

Authors:  Jin-Ping Li; Yin-Xue Yang; Qi-Lun Liu; Zhi-Wei Zhou; Shu-Ting Pan; Zhi-Xu He; Xueji Zhang; Tianxin Yang; Si-Yuan Pan; Wei Duan; Shu-Ming He; Xiao-Wu Chen; Jia-Xuan Qiu; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2015-02-17       Impact factor: 4.162

Review 5.  Crosstalk between apoptosis and autophagy: molecular mechanisms and therapeutic strategies in cancer.

Authors:  Abdelouahid El-Khattouti; Denis Selimovic; Youssef Haikel; Mohamed Hassan
Journal:  J Cell Death       Date:  2013-08-18

6.  The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.

Authors:  Jin-Ping Li; Yin-Xue Yang; Qi-Lun Liu; Shu-Ting Pan; Zhi-Xu He; Xueji Zhang; Tianxin Yang; Xiao-Wu Chen; Dong Wang; Jia-Xuan Qiu; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2015-03-16       Impact factor: 4.162

7.  Early and delayed intervention with rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice.

Authors:  Jagan M R Patlolla; Levy Kopelovich; Li Qian; Yuting Zhang; Gaurav Kumar; Venkateshwar Madka; Altaf Mohammed; Laura Biddick; Michael Sadeghi; Stan Lightfoot; Chinthalapally V Rao
Journal:  Oncol Rep       Date:  2015-09-16       Impact factor: 3.906

Review 8.  Broad targeting of resistance to apoptosis in cancer.

Authors:  Ramzi M Mohammad; Irfana Muqbil; Leroy Lowe; Clement Yedjou; Hsue-Yin Hsu; Liang-Tzung Lin; Markus David Siegelin; Carmela Fimognari; Nagi B Kumar; Q Ping Dou; Huanjie Yang; Abbas K Samadi; Gian Luigi Russo; Carmela Spagnuolo; Swapan K Ray; Mrinmay Chakrabarti; James D Morre; Helen M Coley; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Amedeo Amedei; Elena Niccolai; Amr Amin; S Salman Ashraf; William G Helferich; Xujuan Yang; Chandra S Boosani; Gunjan Guha; Dipita Bhakta; Maria Rosa Ciriolo; Katia Aquilano; Sophie Chen; Sulma I Mohammed; W Nicol Keith; Alan Bilsland; Dorota Halicka; Somaira Nowsheen; Asfar S Azmi
Journal:  Semin Cancer Biol       Date:  2015-04-28       Impact factor: 15.707

9.  Stathmin1 increases radioresistance by enhancing autophagy in non-small-cell lung cancer cells.

Authors:  Xi Zhang; Jingfen Ji; Yu Yang; Juan Zhang; Liangfang Shen
Journal:  Onco Targets Ther       Date:  2016-04-29       Impact factor: 4.147

10.  Prognostic and clinicopathological significance of Beclin-1 in non-small-cell lung cancer: a meta-analysis.

Authors:  Tianliang Zheng; Deping Li; Zhanfeng He; Shuaibing Feng; Song Zhao
Journal:  Onco Targets Ther       Date:  2018-07-19       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.